Grufity logo
Grufity logo

Latest Checkpoint Capital L.P. Stock Portfolio

$278Million– No. of Holdings #8

Checkpoint Capital L.P. Performance:
2026 Q1: -11.33%YTD: -11.33%2025: 33.77%
Performance for 2026 Q1 is -11.33%, and YTD is -11.33%, and 2025 is 33.77%.

About Checkpoint Capital L.P. and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Checkpoint Capital L.P. reported an equity portfolio of $278.7 Millions as of 31 Mar, 2026.

The top stock holdings of Checkpoint Capital L.P. are ARGX, RYTM, RVMD. The fund has invested 40.1% of it's portfolio in ARGENX SE and 38.3% of portfolio in RHYTHM PHARMACEUTICALS INC.

They significantly reduced their stock positions in DISC MEDICINE INC and REVOLUTION MEDICINES INC (RVMD). Checkpoint Capital L.P. opened new stock positions in SEPTERNA INC, CRINETICS PHARMACEUTICALS IN (CRNX) and TREVI THERAPEUTICS INC (TRVI). The fund showed a lot of confidence in some stocks as they added substantially to RHYTHM PHARMACEUTICALS INC (RYTM), CYTOKINETICS INC (CYTK) and ARGENX SE (ARGX).
Checkpoint Capital L.P. Equity Portfolio Value
Last Reported on: 15 May, 2026

Checkpoint Capital L.P. Annual Return Estimates Vs S&P 500

Our best estimate is that Checkpoint Capital L.P. made a return of -11.33% in the last quarter. In trailing 12 months, it's portfolio return was 27.97%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
septerna inc2,410,210
crinetics pharmaceuticals in1,461,150
trevi therapeutics inc596,500
New stocks bought by Checkpoint Capital L.P.

Additions

Ticker% Inc.
rhythm pharmaceuticals inc23.68
cytokinetics inc7.9
argenx se7.75
Additions to existing portfolio by Checkpoint Capital L.P.

Reductions

Ticker% Reduced
disc medicine inc-36.72
revolution medicines inc-29.04
Checkpoint Capital L.P. reduced stake in above stock

Sold off

None of the stocks were completely sold off by Checkpoint Capital L.P.

Sector Distribution

Checkpoint Capital L.P. has about 52.5% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare52.5
Others47.5

Market Cap. Distribution

Checkpoint Capital L.P. has about 9.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
Category%
UNALLOCATED47.5
MID-CAP43.1
LARGE-CAP9.2

Stocks belong to which Index?

About 52.5% of the stocks held by Checkpoint Capital L.P. either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200052.5
Others47.5
Top 5 Winners (%)%
RVMD
revolution medicines inc
18.9 %
CYTK
cytokinetics inc
3.6 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
5.6 M
CYTK
cytokinetics inc
0.4 M
Top 5 Losers (%)%
RYTM
rhythm pharmaceuticals inc
-17.3 %
disc medicine inc
-15.9 %
ARGX
argenx se
-12.8 %
Top 5 Losers ($)$
RYTM
rhythm pharmaceuticals inc
-22.3 M
ARGX
argenx se
-16.3 M
disc medicine inc
-5.7 M

Checkpoint Capital L.P. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Checkpoint Capital L.P.

Checkpoint Capital L.P. has 8 stocks in it's portfolio. RYTM proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Checkpoint Capital L.P. last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions